Director at Kewaunee Scientific (KEQU) receives 2,013-share equity award

Rhea-AI Filing Summary

GEHL KEITH M reported acquisition or exercise transactions in this Form 4 filing.

Kewaunee Scientific director Keith M. Gehl received a grant of 2,013 shares of Common Stock on May 1, 2026. The shares were awarded under the company’s 2023 Omnibus Incentive Plan as the equity portion of his annual compensation and were granted at $0.00 per share. Following this award, he directly holds 22,409 shares of Kewaunee Scientific common stock.

Insider Trade Summary

1 transaction reported

Mixed 1 txn

Insider GEHL KEITH M

Role null

Type	Security	Shares	Price	Value
Grant/Award	Common Stock	2,013	$0.00	--

Holdings After Transaction: Common Stock — 22,409 shares (Direct, null)

Footnotes (1)

1. [object Object]

Key Figures

Equity award shares: 2,013 shares Grant price: $0.00 per share Shares held after award: 22,409 shares +1 more

4 metrics

Equity award shares 2,013 shares Common Stock grant on May 1, 2026

Grant price $0.00 per share Equity portion of annual compensation

Shares held after award 22,409 shares Director’s direct Common Stock holdings post‑grant

Acquisition transactions 1 transaction Grant, award, or other acquisition (Code A)

Key Terms

2023 Omnibus Incentive Plan, equity portion of the reporting person's annual compensation, Grant, award, or other acquisition, Common Stock

4 terms

2023 Omnibus Incentive Plan financial

"Shares awarded under the Company's 2023 Omnibus Incentive Plan, representing the equity portion..."

equity portion of the reporting person's annual compensation financial

"representing the equity portion of the reporting person's annual compensation."

Grant, award, or other acquisition financial

"transaction_code_description: Grant, award, or other acquisition"

Common Stock financial

"security_title: Common Stock"

Common stock represents ownership shares in a company, giving investors a stake in its success and a say in important decisions through voting rights. It is the most common type of stock traded on markets and can provide income through dividends, as well as potential for value growth. For investors, holding common stock means sharing in the company’s profits and risks.

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

GEHL KEITH M

(Last) (First) (Middle)

2700 WEST FRONT STREET

(Street)

STATESVILLE NORTH CAROLINA 28677

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
KEWAUNEE SCIENTIFIC CORP /DE/ [ KEQU ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
05/01/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	05/01/2026		A		2,013	A	$0(1)	22,409	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Shares awarded under the Company's 2023 Omnibus Incentive Plan, representing the equity portion of the reporting person's annual compensation.

Remarks:

	/s/ Donald T. Gardner III, Attorney-in-fact	05/04/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What did Kewaunee Scientific (KEQU) director Keith M. Gehl report in this Form 4?

He reported receiving a grant of 2,013 shares of Kewaunee Scientific Common Stock. The award represents the equity portion of his annual compensation and was issued under the company’s 2023 Omnibus Incentive Plan at a price of $0.00 per share.

How many Kewaunee Scientific (KEQU) shares does Keith M. Gehl hold after this award?

After the equity award, Keith M. Gehl directly holds 22,409 shares of Kewaunee Scientific Common Stock. This total includes the newly granted 2,013 shares received as part of his annual compensation under the company’s 2023 Omnibus Incentive Plan.

Was the 2,013-share award to Kewaunee Scientific (KEQU) director Keith M. Gehl an open-market purchase?

No, the 2,013-share transaction was coded as an acquisition grant, not an open-market purchase. The shares were awarded at $0.00 per share as compensation under Kewaunee Scientific’s 2023 Omnibus Incentive Plan, rather than being bought on the open market.

What is the nature of the 2,013-share grant reported by Kewaunee Scientific (KEQU) director Keith M. Gehl?

The filing describes the transaction as a grant or award acquisition of 2,013 Common Stock shares. A footnote explains these shares were awarded under the 2023 Omnibus Incentive Plan and represent the equity portion of the director’s annual compensation from Kewaunee Scientific.

Which compensation plan was used for Keith M. Gehl’s latest Kewaunee Scientific (KEQU) share award?

The award was made under Kewaunee Scientific’s 2023 Omnibus Incentive Plan. According to the filing footnote, the 2,013 shares of Common Stock granted to director Keith M. Gehl represent the equity portion of his annual compensation from the company.